ASND vs. KEN
ASND (Ascendis Pharma A/S) and KEN (Kenon Holdings Ltd.) are both stocks. ASND operates in Biotechnology (Healthcare), while KEN operates in Utilities - Regulated Electric (Utilities). Over the past 10 years, ASND returned 31.35%/yr vs 42.04%/yr for KEN. At a 0.12 correlation, their price movements are largely independent.
Performance
ASND vs. KEN - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ASND achieves a -3.48% return, which is significantly lower than KEN's 20.71% return. Over the past 10 years, ASND has underperformed KEN with an annualized return of 31.35%, while KEN has yielded a comparatively higher 42.04% annualized return.
ASND
- 1D
- -2.20%
- 1M
- -13.76%
- YTD
- -3.48%
- 6M
- -0.63%
- 1Y
- 18.92%
- 3Y*
- 30.47%
- 5Y*
- 9.47%
- 10Y*
- 31.35%
KEN
- 1D
- 1.93%
- 1M
- -13.88%
- YTD
- 20.71%
- 6M
- 30.64%
- 1Y
- 116.81%
- 3Y*
- 61.79%
- 5Y*
- 34.36%
- 10Y*
- 42.04%
ASND vs. KEN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ASND Ascendis Pharma A/S | -3.48% | 54.89% | 9.31% | 3.13% | -9.22% | -19.34% | 19.88% | 122.06% | 56.39% | 97.92% |
KEN Kenon Holdings Ltd. | 20.71% | 126.18% | 62.44% | -19.16% | -23.73% | 93.65% | 57.17% | 50.73% | 23.06% | 85.88% |
Correlation
The correlation between ASND and KEN is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.08 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.08 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.15 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.12 |
Correlation (All Time) Calculated using the full available price history since Jan 29, 2015 | 0.12 |
Fundamentals
ASND:
$13.28B
KEN:
$4.06B
ASND:
$8.08
KEN:
$1.54
ASND:
25.47
KEN:
49.63
ASND:
0.12
KEN:
8.33
ASND:
14.88
KEN:
4.01
ASND:
27.18
KEN:
2.71
ASND:
$867.51M
KEN:
$1.01B
ASND:
$764.89M
KEN:
$166.82M
ASND:
-$6.94M
KEN:
$339.95M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ASND vs. KEN — Risk / Return Rank
ASND
KEN
ASND vs. KEN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Ascendis Pharma A/S (ASND) and Kenon Holdings Ltd. (KEN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ASND | KEN | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.49 | ||
| Sortino ratioReturn per unit of downside risk | -2.42 | ||
| Omega ratioGain probability vs. loss probability | 1.12 | 1.44 | -0.33 |
| Calmar ratioReturn relative to maximum drawdown | 1.09 | 5.49 | -4.40 |
| Martin ratioReturn relative to average drawdown | 3.52 | 19.50 | -15.98 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ASND | KEN | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.52 | 3.01 | -2.49 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.20 | 0.87 | -0.67 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.62 | 1.01 | -0.39 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.46 | 0.75 | -0.29 |
Drawdowns
ASND vs. KEN - Drawdown Comparison
The maximum ASND drawdown since its inception was -61.72%, smaller than the maximum KEN drawdown of -69.20%. Use the drawdown chart below to compare losses from any high point for ASND and KEN.
Loading charts...
Drawdown Indicators
| ASND | KEN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -61.72% | -69.20% | +7.48% |
Max Drawdown (1Y)Largest decline over 1 year | -17.62% | -21.39% | +3.77% |
Max Drawdown (3Y)Largest decline over 3 years | -29.15% | -32.27% | +3.12% |
Max Drawdown (5Y)Largest decline over 5 years | -60.46% | -69.20% | +8.74% |
Max Drawdown (10Y)Largest decline over 10 years | -61.72% | -69.20% | +7.48% |
Current DrawdownCurrent decline from peak | -17.62% | -19.88% | +2.26% |
Average DrawdownAverage peak-to-trough decline | -18.71% | -23.18% | +4.47% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.45% | 6.02% | -0.57% |
Volatility
ASND vs. KEN - Volatility Comparison
Ascendis Pharma A/S (ASND) and Kenon Holdings Ltd. (KEN) have volatilities of 14.11% and 14.44%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ASND | KEN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.11% | 14.44% | -0.33% |
Volatility (6M)Calculated over the trailing 6-month period | 29.67% | 29.95% | -0.28% |
Volatility (1Y)Calculated over the trailing 1-year period | 37.02% | 39.14% | -2.12% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 48.63% | 39.77% | +8.86% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 51.11% | 41.90% | +9.21% |
Dividends
ASND vs. KEN - Dividend Comparison
ASND has not paid dividends to shareholders, while KEN's dividend yield for the trailing twelve months is around 5.03%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ASND Ascendis Pharma A/S | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
KEN Kenon Holdings Ltd. | 5.03% | 7.24% | 11.18% | 11.46% | 25.00% | 7.35% | 7.41% | 5.75% | 96.34% | 0.00% | 0.00% | 45.52% |
Financials
ASND vs. KEN - Financials Comparison
This section allows you to compare key financial metrics between Ascendis Pharma A/S and Kenon Holdings Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ASND and KEN have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
KEN has higher volatility (14.44%) compared to ASND (14.11%). In terms of maximum drawdown, ASND dropped -61.72% vs KEN's -69.20%.
KEN currently has the higher Sharpe Ratio (3.01 vs 0.52), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ASND and KEN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer